Viamet Pharmaceuticals Holdings (VMET) Withdrawn

Biotech developing small molecule metalloenzyme inhibitors to treat fungal diseases.

Health Care - Biotechnology

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Viamet Pharmaceuticals Holdings IPO News more
  • .
IPO Data
IPO File Date 04/08/2016
Offer Price
Price Range $14.00 - $16.00
Offer Shares (mm) 5.7
Deal Size ($mm) $86
 
IPO Data
IPO Date
Offer Price
Price Range $14.00 - $16.00
Offer Shares (mm) 5.7
Deal Size ($mm) $$86
 
Underwriters
more
Business Overview
Biotech developing small molecule metalloenzyme inhibitors to treat fungal diseases.
Biotech developing small molecule metalloenzyme inhibitors to treat fungal diseases.
more
Company Data
Headquarters Durham, NC
Founded 2004
Employees 29
Website www.viamet.com
 

Performance vs. IPO Index (IPOUSA)